-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MqnukfRLQh5RJUHUxxRkXteNFs8qJYcKp5hfNitW3pbjZDSnMFSqUSPLwmbKjGs5 F9f/YCb7adsc7iHcFm7M8g== 0000758722-00-000026.txt : 20000215 0000758722-00-000026.hdr.sgml : 20000215 ACCESSION NUMBER: 0000758722-00-000026 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991231 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PARACELSUS HEALTHCARE CORP CENTRAL INDEX KEY: 0000758722 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 953565943 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: SEC FILE NUMBER: 001-12055 FILM NUMBER: 540618 BUSINESS ADDRESS: STREET 1: 515 W GREENS RD STREET 2: STE 800 CITY: HOUSTON STATE: TX ZIP: 77067 BUSINESS PHONE: 2817745100 MAIL ADDRESS: STREET 1: 515 W GREENS RD STREET 2: STE 800 CITY: HOUSTON STATE: TX ZIP: 77067 COMPANY DATA: COMPANY CONFORMED NAME: SCHNITZLER PETER CENTRAL INDEX KEY: 0001085125 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR IRS NUMBER: 953565943 FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 515 W GREENS ROAD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77067 BUSINESS PHONE: 2817745200 MAIL ADDRESS: STREET 1: 515 W GREENS ROAD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77067 5 1 FORM 5 - 12/31/99 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ( ) Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instructions 1(b). ( ) Form 3 Holdings Reported ( ) Form 4 Transactions Reported 1. Name and Address of Reporting Person Schnitzler, Peter Paracelsus-Kliniken-Deutschland GmbH Am Natruper Holz 69 D-49076 Oshabrueck, Germany 2. Issuer Name and Ticker or Trading Symbol Paracelsus Healthcare Corporation PLS 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for Month/Year 12/31/99 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) (X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) Director 7. Individual or Joint/Group Reporting (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect | |Transaction| or Disposed of (D) | Securities |ect | Beneficial Ownership | |Date |Code| | Beneficially |(D)or | | | | | | A/| | Owned at |Indir | | | | | Amount | D | Price | End of Year |ect(I)| | ___________________________________________________________________________________________________________________________________| No Change | | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________ Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1.Title of Derivative |2.Con |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of| Security |version |Transaction rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect | |or Exer |Date |Code| rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial | |cise Pr | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership | |ice of | | | posed of(D) |Day/Year) | |rity |Benefi |or | | |Deriva | | | |Date |Expir| | |ficially |Ind| | |tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| | |Secu | | | | D |cisa-|Date | of Shares | |End of |ct | | |rity | | | Amount | |ble | | | |Year |(I)| | ___________________________________________________________________________________________________________________________________| Options to purchase comm|$0.625 |10/20|A |10,000 |A |10/20|(a) |Common Stock|10,000 | |10,000 |D | | on stock | |/99 | | | |/99 | | | | | | | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________|
Explanation of Responses: (a) Expire upon the first to occur: (i) October 20, 2009, (ii) 90th day after termination or resignation as director of the Company for reason other than cause, death or disability and (iii) 120th day after termination as director of the Company for death or disability. SIGNATURE OF REPORTING PERSON Mai-Phuong N. Garland, Attorney-in-Fact DATE 02/14/2000 -----END PRIVACY-ENHANCED MESSAGE-----